Join NCATS Wednesday, December 8, 2021, from 2:00 pm to 3:30 p.m. ET. for a panel discussion with SBIR/STTR grantees who have used NCATS funding and resources to develop transformative innovations in translational science. Hear about their innovations, their inspirations, and the lessons they have learned while building their businesses, Recursion Pharmaceuticals, Intabio and GoDX.

For ten years, the National Center for Advancing Translational Sciences (NCATS) has worked with researchers, clinicians, entrepreneurs, patients and other stakeholder to design new approaches and technologies that ultimately will deliver more treatments to more people more quickly.

The stories shared here by researchers and others are about what they do, what inspires their work and why they find translational science exciting.

Moderator:

• Lili M. Portilla, M.P.A., Director, Office of Strategic Alliances, NCATS-NIH

Panelists:

• Chris Gibson, Ph.D., Co-Founder & CEO, Recursion Pharmaceuticals
• Lena Wu, Ph.D., Co-Founder and Former CEO and President, Intabio, Inc.
• Chang Hee Kim, Ph.D., CEO, GoDx, Inc.

Individuals from the following groups are encouraged to attend:

• Small biotech and/or life sciences technology businesses
• Academic entrepreneurs
• Technology transfer organizations
• Entrepreneurs from women-owned and socially and economically disadvantaged (8a) small businesses